On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Insilicotrials Technologies S.p.a.'s own share of each project, not the project's full budget.
- Horizon 2020€2.1M · 4 projects
- Horizon Europe€1.6M · 3 projects
- EU4Health Programme (EU4H)€53k · 2 projects
Projects
9 EU-funded projects, newest first. Each links to the official record.
- MALASSAPartner
A NOVEL MONOCLONAL ANTIBODY SOLUTION FOR LASSA FEVER - TRANSFORMING PROPHYLAXIS AND TREATMENT TO IMPROVE HEALTH SECURITY AND PANDEMIC RESILIENCE
Horizon Europe · 2026–2031 · Project on CORDIS ↗
€875ktheir share - EUPOPMEDPartner
EUropean Platform for Orphan and Paediatric MEdical Devices
EU4Health Programme (EU4H) · 2026–2028 · Project on the EU portal ↗
€33ktheir share - DeCODePartner
Develop Child and Orphan Device Evaluation support
EU4Health Programme (EU4H) · 2024–2026 · Project on the EU portal ↗
€20ktheir share - SMASH-HCMPartner
Stratification, Management, and Guidance of Hypertrophic Cardiomyopathy Patients using Hybrid Digital Twin Solutions
Horizon Europe · 2024–2027 · Project on CORDIS ↗
€605ktheir share - METASTRAPartner
COMPUTER-AIDED EFFECTIVE FRACTURE RISK STRATIFICATION OF PATIENTS WITH VERTEBRAL METASTASES FOR PERSONALISED TREATMENT THROUGH ROBUST COMPUTATIONAL MODELS VALIDATED IN CLINICAL SETTINGS
Horizon Europe · 2023–2028 · Project on CORDIS ↗
€130ktheir share - SimCardioTestPartner
Simulation of Cardiac Devices & Drugs for in-silico Testing and Certification
Horizon 2020 · 2021–2025 · Project on CORDIS ↗
€969ktheir share - ISWPartner
In Silico World: Lowering barriers to ubiquitous adoption of In Silico Trials
Horizon 2020 · 2021–2024 · Project on CORDIS ↗
€284ktheir share - BRAINTEASERPartner
BRinging Artificial INTelligencE home for a better cAre of amyotrophic lateral sclerosis and multiple SclERosis
Horizon 2020 · 2021–2025 · Project on CORDIS ↗
€552ktheir share - Disc4AllPartner
Training network to advance integrated computational simulations in translational medicine, applied to intervertebral disc degeneration
Horizon 2020 · 2020–2025 · Project on CORDIS ↗
€262ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Alma Mater Studiorum - Universita di BolognaItaly · 3 shared projects
- Katholieke Universiteit LeuvenBelgium · 2 shared projects
- Institut National de la Sante et de la Recherche MedicaleFrance · 2 shared projects
- Universiteit TwenteNetherlands · 2 shared projects
- The University of SheffieldUnited Kingdom · 2 shared projects
- Universidad Pompeu FabraSpain · 2 shared projects
- Universite de LiegeBelgium · 2 shared projects
- Istituto Ortopedico RizzoliItaly · 2 shared projects
- Virtual Physiological Human Institute for Integrative Biomedical Research vzwBelgium · 2 shared projects
- Conect4children StichtingNetherlands · 2 shared projects
- Insilicotrials Technologies BVNetherlands · 2 shared projects
- Commissariat A L Energie Atomique et aux Energies AlternativesFrance · 1 shared project
- The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 1 shared project
- Eidgenoessische Technische Hochschule ZuerichSwitzerland · 1 shared project
- Ludwig-Maximilians-Universitaet MuenchenGermany · 1 shared project
- Politecnico di MilanoItaly · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- amyotrophic lateral sclerosis
- artificial intelligence
- biophysics
- cardiology
- computer security
- endocrinology
- multiple sclerosis
- public health
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.
